These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2131715)
1. [IgM monoclonal gammopathy in plasmacytic neoplasms]. Kraj M; Kopeć I; Rostkowska J; Pogłód R; Maj S Acta Haematol Pol; 1990; 21(2):153-65. PubMed ID: 2131715 [TBL] [Abstract][Full Text] [Related]
2. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin. Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Kyle RA; Rajkumar SV Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088 [TBL] [Abstract][Full Text] [Related]
4. [Monoclonal gammopathies of undetermined significance called "MGUS"]. Clément F Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215 [TBL] [Abstract][Full Text] [Related]
5. The laboratory diagnosis of plasma cell myeloma and related disorders. Nawab RA; Azar HA Orthop Clin North Am; 1979 Apr; 10(2):391-404. PubMed ID: 109804 [TBL] [Abstract][Full Text] [Related]
6. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells. Pérez-Persona E; Mateo G; García-Sanz R; Mateos MV; de Las Heras N; de Coca AG; Hernández JM; Galende J; Martín-Nuñez G; Bárez A; Alonso JM; Martín A; López-Berges C; Orfao A; San Miguel JF; Vidriales MB Br J Haematol; 2010 Jan; 148(1):110-4. PubMed ID: 19821821 [TBL] [Abstract][Full Text] [Related]
7. Biclonal gammopathy in multiple myeloma: a case report. Bakta IM; Sutarka IN Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208 [TBL] [Abstract][Full Text] [Related]
8. 'Mu' heavy chain type 'non-excretory' myeloma. Guglielmo P; Granata P; Di Raimondo F; Lombardo T; Giustolisi R; Cacciola E Scand J Haematol; 1982 Jul; 29(1):36-40. PubMed ID: 6812210 [TBL] [Abstract][Full Text] [Related]
9. Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy. Takeshita A Clin Exp Immunol; 1986 Dec; 66(3):625-32. PubMed ID: 3568450 [TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathies associated with monoclonal proteins: a clinical review. Kelly JJ Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604 [TBL] [Abstract][Full Text] [Related]
11. A GEIL flow cytometry consensus proposal for quantification of plasma cells: application to differential diagnosis between MGUS and myeloma. Frébet E; Abraham J; Geneviève F; Lepelley P; Daliphard S; Bardet V; Amsellem S; Guy J; Mullier F; Durrieu F; Venon MD; Leleu X; Jaccard A; Faucher JL; Béné MC; Feuillard J; Cytometry B Clin Cytom; 2011 May; 80(3):176-85. PubMed ID: 21520405 [TBL] [Abstract][Full Text] [Related]
12. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance? Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099 [TBL] [Abstract][Full Text] [Related]
13. IgM myeloma: a report of four cases. Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells. Sezer O; Heider U; Zavrski I; Possinger K Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies. Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356 [TBL] [Abstract][Full Text] [Related]
17. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark. Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB; Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249 [TBL] [Abstract][Full Text] [Related]
18. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance. Jerez A; Ortuño FJ; Osma Mdel M; Español I; González AD; Roldán V; de Arriba F; Vicente V Ann Med; 2009; 41(7):547-58. PubMed ID: 19634064 [TBL] [Abstract][Full Text] [Related]
19. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. McMaster ML; Caporaso N Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080 [TBL] [Abstract][Full Text] [Related]